XBP1 and amelogenesis imperfecta type 1G: Strikingly, IRE1α inhibitors (STF-083010) completely block the splicing of XBP1 (a target of IRE1α) in adipocytes (Figure 5D), and the inhibition of IRE1α by treatment with 4μ8c led to significant remission of ERS (Figure 5E).